Objective: We evaluated the modified diagnostic criteria for disseminated intravascular coagulation (
Introduction
Disseminated intravascular coagulation (DIC) is often associated with severe organ failure and a bleeding tendency in various underlying diseases [1] [2] [3] [4] and is reported to be associated with a high rate of mortality. [5] [6] [7] Several diagnostic criteria for DIC have been proposed, including the Japanese Ministry Health, Labor and Welfare (JMHLW) DIC diagnostic criteria, 8 the International Society of Thrombosis and Haemostasis (ISTH) overt-DIC diagnostic criteria, 9 and the Japanese Association for Acute Medicine (JAA) DIC diagnostic criteria. 10 In these 3 diagnostic criteria, global coagulation tests (GCTs), such as the prothrombin time (PT), platelet count (PLT), fibrinogen and fibrin and fibrinogen degradation products (FDP), or D-dimer, are primarily used for scoring to evaluate the severity of DIC. 1, 3 The ISTH guidelines 11 for DIC recommended the use of such a scoring system for the diagnosis or monitoring of DIC. Among the 3 diagnostic criteria, 12 the ISTH overt-DIC diagnostic criteria displays high sensitivity but low specificity in the diagnosis of DIC. Given that the 3 DIC diagnostic criteria use similar GCTs, their diagnostic abilities for DIC may be similar. DIC score increased. 13 These findings suggest that an early diagnosis and treatment are essential for improving the outcomes of patients with DIC. It is therefore necessary to change the GCTs and hemostatic molecular markers (such as soluble fibrin [SF], plasmin-plasmin inhibitor [PI] complex [PPIC], and thrombin-antithrombin [AT] complex [TAT] ) that are used in order to diagnose DIC at an early stage. 14 Although nonovert DIC was proposed by the ISTH/SSC subcommittee, the criteria for diagnosing early-phase DIC have not been well established. [15] [16] [17] [18] Recently, the Japanese Society of Thrombosis and Hemostasis (JSTH) proposed a modified version of the JMHLW DIC criteria. 19 In the present study, this scoring system was evaluated for diagnosing DIC in infectious patients with and without DIC. Table 1 shows the modified JSTH DIC criteria for patients with infectious diseases.
Materials and Methods
The present study included a total of 108 patients having infectious diseases with suspected DIC who were treated from January 1, 1989, to December 31, 2014. Sixty-three patients were diagnosed according to the JMHLW diagnostic criteria, 8 and it was possible to determine the presence of hemostatic abnormalities within 7 days before the onset of DIC in 22 patients; these were considered to be pre-DIC cases. 20 Forty-five patients did not develop DIC during their clinical course (non-DIC; Table 2 ). The study protocol was approved by the Human Ethics Review Committee of the Mie University School of Medicine. This was carried out in accordance with the principle of the Declaration of Helsinki. The cases in which one or more of the following laboratory findings were present were included in the following study: a PLT of F 120 Â 10 3 per/mL; an FDP value of G 10 mg/mL; a fibrinogen level of F 1 g/L; and a PT ratio of G 1.25.
The PT, fibrinogen, PLT, D-dimer, SF, TAT, and FDP levels were measured based on the methods of previous reports. [12] [13] [14] 21, 22 The AT activity was measured by heparin cofactor activity using a Chromorate ATIII (LSI Medience Corporation, Tokyo, Japan) or a Berichrome-Antithrombin kit (Behringwerke AG, Marburg, Germany). The plasma levels of SF, soluble fibrin monomer complex (SFMC), and D-dimer were measured by a latex immune agglutination test using LPIA SF (LSI Medience Corporation) or an Enzymum test SFMC (Behringwerke AG) and LPIA D-dimer (LSI Medience Corporation). The plasma levels of TAT were measured by Enzygnost TAT (Behringwerke AG) or Stacia TAT (LSI Medience Corporation).
Statistical Analysis
The data are expressed as the median (25th to 75th percentile). The differences between the groups were examined for statistical significance using the Mann-Whitney U test. The efficacy of the DIC diagnostic criteria was evaluated by a receiveroperating characteristic (ROC) analysis. P values of F.05 were considered to indicate statistical significance. All of the statistical analyses were performed using the Stat Flex, software program (version 6; Artec Co Ltd, Osaka, Japan).
Results
There were no significant differences in the age or sex of the patients with DIC, pre-DIC, and non-DIC as diagnosed by the JMHLW DIC diagnostic criteria ( Table 3) non-DIC group ( Table 3 ). The levels of hemostatic markers are shown in Table 4 . Although the values of PT ratio, PLT, FDP, AT, TAT, and SF/SFMC in the patients with DIC differed significantly from those in the non-DIC patients, there were no significant differences between the pre-DIC and the non-DIC patients. The mortality rate was higher in the patients with DIC and pre-DIC patients than in the non-DIC patients. The rate of resolution from DIC was similar in both the DIC and the pre-DIC groups. In the diagnosis of DIC in patients without pre-DIC (Table 5) , the cutoff value of the DIC score was decided according to the cross point between the sensitivity curve and the 1-specificity curve (Figure 1) . (Table 6) , the cutoff value of the DIC score for ''DIC and pre-DIC'' was the same as that for ''DIC.'' The lowest AUC value was 0.882 in ''GCT'' 
Discussion
Suspected DIC patients were classified into 3 groups: overt-DIC, pre-DIC, and negative DIC (non-DIC). A previous report 13 showed that the outcome of DIC was improved by early treatment. Although the early diagnosis of DIC is considered to be important for improving its prognosis, the diagnostic criteria for pre-DIC have not been established. Previously, several reports 3, 13 referred to the state within 1 week before the onset of DIC as pre-DIC. In the present study, there were no significant differences in any markers in the pre-DIC and non-DIC group. The ISTH guidance for the diagnosis and treatment of DIC recommends the diagnosis of DIC by a scoring system rather than by a single marker. 11 The JAA proposed DIC diagnostic criteria that use GCT scores to diagnose the early phase of DIC 10 ; they show high sensitivity but low specificity for DIC. 12 Several modified diagnostic criteria for nonovert-DIC have been proposed that use GCT scores, hemostatic molecular marker levels, and the change in GCT values [15] [16] [17] [18] ; however, these have not been sufficiently evaluated. In the DIC group, which was diagnosed according to the JMHLW DIC diagnostic criteria, the median ISTH overt DIC score and the JAA DIC score using the GCT score were 5.0 and 5.0, respectively. In addition, GCT score displayed a high AUC value in the ROC analysis, suggesting that GCTs are useful in the diagnosis of overt-DIC. In contrast, in the diagnosis of DIC in patients with pre-DIC, the AUC and odd's ratio were low in the GCT score. The addition of AT reduced PLT and SF/TAT increased the AUC and odd's ratio, suggesting that, in combination with hemostatic molecular markers, the change in the PLT and GCT score values could increase both the sensitivity and the specificity in the diagnosis of both DIC and early DIC (DIC þ pre-DIC). An ROC analysis also showed that the adequate cutoff value for the diagnosis of DIC was 5 points instead of the 6 points proposed by the JSTH. This is because the JSTH committee for the DIC diagnostic criteria only focused on the suitability of each hemostatic marker for the diagnosis of DIC, and not on the scoring system for the DIC diagnostic criteria, which use a combination of hemostatic markers, the GCT score, and a reduced PLT value.
In conclusion, the modified JMHLW diagnostic criteria for DIC, which use the GCT score, a reduced PLT value, and the hemostatic molecular marker levels, can be used to diagnose both overt-DIC and pre-DIC. 
